Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating qi deficiency and blood stasis-type apoplexy and preparation method thereof

A technology for qi deficiency and blood stasis and a composition is applied in the field of pharmaceutical compositions for treating qi deficiency and blood stasis type apoplexy and the field of preparation thereof, which can solve the problems that the drugs are not targeted and cannot be treated according to specific conditions, and can prevent heart disease and control, strict formulation, cholesterol and triglyceride lowering effect

Inactive Publication Date: 2015-02-25
刘庆春
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although there are many drugs for the treatment of stroke, most of them are not highly targeted and cannot be treated according to specific conditions. Therefore, it is urgent to develop more targeted drugs to classify strokes.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] A pharmaceutical composition for treating stroke due to qi deficiency and blood stasis, comprising main ingredients and auxiliary materials. The main ingredients are composed of the following raw materials in parts by weight: 20 parts of bindweed root, 50 parts of blue flower ginseng, 14 parts of wild goose fat, silk cotton 6 parts of wood, 30 parts of red maple lotus, 12 parts of medicinal celery root, 15 parts of madder root, 12 parts of summer no, 14 parts of Acanthopanax, 23 parts of small red ginseng, 18 parts of ginseng, 8 parts of white plum blossom, asarum 3 parts, 3 parts of saponins, 25 parts of bayberry root, 10 parts of agarwood, 35 parts of limonium, 24 parts of rock sugar grass, 60 parts of barley, 18 parts of big belly skin, 18 parts of brocade, 25 parts of phoenix leaves; The auxiliary materials include: 3 parts of evening primrose oil, 1.5 parts of knotweed extract, and 1.6 parts of lecithin.

[0028] Wherein, the Polygonum cuspidatum extract refers to ...

Embodiment 2

[0037] A pharmaceutical composition for treating stroke caused by qi deficiency and blood stasis, including main ingredients and auxiliary materials. 9 parts of wood, 45 parts of red maple lotus, 26 parts of medicinal celery root, 20 parts of madder root, 18 parts of Xia Wu, 23 parts of Acanthopanax, 34 parts of small red ginseng, 24 parts of ginseng, 11.5 parts of white plum blossom, Asarum 10.5 parts, 6.5 parts of saponins, 35 parts of bayberry root, 15 parts of agarwood, 50 parts of limonium, 42 parts of rock sugar grass, 75 parts of barley, 25 parts of big belly skin, 29 parts of brocade, 35 parts of phoenix leaves; The auxiliary materials include: evening primrose oil 4.5 parts, knotweed extract 1.95 parts, lecithin 1.9 parts.

[0038] Wherein, the Polygonum cuspidatum extract refers to resveratrol glycosides. Resveratrol glycosides are the main functional components of Polygonum cuspidatum. Studies have shown that it has a significant effect on cardiomyocytes, vascular...

Embodiment 3

[0047] A pharmaceutical composition for treating qi-deficiency and blood-stasis type stroke, including main ingredients and auxiliary materials, the main ingredients are composed of the following raw materials in parts by weight: 30 parts of Convolvulaceae root, 100 parts of blue flower ginseng, 30 parts of wild goose fat, silk cotton 12 parts of wood, 60 parts of red maple lotus, 40 parts of medicinal celery root, 25 parts of madder root, 24 parts of Xia Wu, 32 parts of Acanthopanax, 45 parts of small red ginseng, 30 parts of ginseng, 15 parts of white plum blossom, asarum 18 parts, 10 parts of saponins, 45 parts of bayberry root, 20 parts of agarwood, 65 parts of limonium, 60 parts of rock sugar grass, 90 parts of barley, 32 parts of big belly skin, 40 parts of brocade, 45 parts of phoenix leaves; The auxiliary materials include: 6 parts of evening primrose oil, 2.4 parts of knotweed extract, and 2.2 parts of lecithin.

[0048] Wherein, the Polygonum cuspidatum extract refer...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating qi deficiency and blood stasis-type apoplexy and a preparation method thereof. The pharmaceutical composition comprises scammoniae radix, Wahlenbergia marginata, wild goose fat, euonymus bungeanus, radix artocarpi styracifolii, Pternopetalum nudicaule, madder root, corydalis amabilis, acanthopanax, Galium elegans, wild chervil, white plum flower, herba asari, gleditsia japonica, bayberry root, aquilaria wood, Limonium sinense, sweet broomwort herb, barley, areca peel, Parthenocissus tricuspidata and phoenix tree leaf as main materials and evening primrose oil, gentrin knotweed extract and phosphatidylcholine bilayer as accessory materials. The pharmaceutical composition is used for treating qi deficiency and blood stasis-type apoplexy symptoms such as hemiplegia, sluggish speech or mutistic, palpitation, loose stool and hand and foot swelling, contains the main medicinal materials with effects of tonifying qi, promoting blood circulation, dredging collaterals, removing stasis, reducing phlegm and inducing resuscitation, tonifying qi and invigorating spleen, and disinhibiting dampness and auxiliary medicinal materials with effects of adjusting blood pressure and blood fat, has good prevention and control effects on hypertension, cerebral apoplexy and heart disease, is safe, has no toxic or side effect and provides a novel drug choice for patients suffering from qi deficiency and blood stasis-type apoplexy.

Description

technical field [0001] The invention relates to the technical field of internal medicine of traditional Chinese medicine, in particular to a pharmaceutical composition for treating stroke of Qi deficiency and blood stasis type and a preparation method thereof. Background technique [0002] Stroke is divided into two types: external wind and internal wind. External wind is caused by feeling external evils (wind evil); The term "stroke" generally referred to in modern times mostly refers to stroke-like symptoms of internal injury and disease, which are mostly caused by inversion of Qi and blood, blockage of cerebral arteries, or blood overflowing in the brain. Brain and spirit diseases mainly manifested by sudden fainting, hemiplegia, limb numbness, speechless tongue, crooked mouth and tongue, numbness in one side of the body, etc. It is also a disease with the characteristics of rapid onset and rapid change, such as frequent changes in wind, evil, and good deeds. [0003] S...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8998A61P9/10
CPCA61K9/1652A61K9/2059A61K9/4858A61K31/685A61K35/57A61K36/185A61K36/23A61K36/254A61K36/268A61K36/30A61K36/34A61K36/37A61K36/39A61K36/47A61K36/48A61K36/60A61K36/66A61K36/704A61K36/736A61K36/74A61K36/80A61K36/835A61K36/87A61K36/889A61K36/8998A61K2236/331A61K2236/333A61K2236/39A61K2300/00
Inventor 刘庆春董广卫
Owner 刘庆春
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com